Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
The Two-State Receptor Model01:29

The Two-State Receptor Model

3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.0K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

860
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
860
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

131.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.4K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncofetal RNA-binding proteins of IGF2BP family suppress IRF-3 and NF-kB dependent transcription downstream of cytosolic RNA sensors.

bioRxiv : the preprint server for biology·2026
Same author

Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.

Oncology reviews·2026
Same author

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia.

Blood neoplasia·2026
Same author

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Haematologica·2026
Same author

Advances in the Understanding of Akt Signaling in Cancers and the Potential of Inhibiting Akt-Driven Tumors Using Small Molecule Inhibitors: An Overview.

Cancers·2026
Same author

Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.

Molecular psychiatry·2026

Related Experiment Video

Updated: Jan 10, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.4K

The serotonin 1B receptor modulates striatal activity differentially based on behavioral context.

Ka H Ng1, Arati Sharma1, Katherine M Nautiyal1

  • 1Department of Psychological and Brain Sciences, Dartmouth College, 6207 Moore Hall, Hanover, NH, 03755 USA.

Biorxiv : the Preprint Server for Biology
|November 24, 2025
PubMed
Summary

Serotonin 1B receptors (5-HT1BR) in the dorsomedial striatum (DMS) modulate reward processing and impulsivity. Loss of 5-HT1BR alters neural activity, impacting goal-directed behaviors and suggesting context-dependent serotonin functions.

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.2K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.7K

Related Experiment Videos

Last Updated: Jan 10, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.4K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.2K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.7K

Area of Science:

  • Neuroscience
  • Behavioral Neuroscience
  • Molecular Neuroscience

Background:

  • The dorsomedial striatum (DMS) is crucial for goal-directed behaviors, integrating inputs from various brain regions.
  • Serotonin neurons, particularly via the serotonin 1B receptor (5-HT1BR), are known to influence DMS function and reward-related behaviors, including impulsivity.
  • Understanding the in vivo role of 5-HT1BR in the DMS during complex behaviors is essential.

Purpose of the Study:

  • To investigate the in vivo effects of serotonin 1B receptors (5-HT1BR) on dorsomedial striatum (DMS) neural activity during goal-directed behavior in mice.
  • To determine how 5-HT1BR loss-of-function impacts medium spiny neuron (MSN) calcium activity in the DMS in response to reward and during waiting periods.

Main Methods:

  • Utilized a genetic 5-HT1BR loss-of-function mouse model.
  • Employed in vivo calcium imaging to record the activity of individual MSNs in the DMS.
  • Assessed neural activity during operant tasks involving responding for reward and waiting periods to measure impulsivity.

Main Results:

  • Loss of 5-HT1BR significantly reduced excitatory MSN calcium responses and increased inhibitory responses post-reward.
  • In impulsivity tasks, 5-HT1BR knockout mice showed a higher proportion of MSNs with increased calcium activity during the waiting period.
  • These findings suggest serotonin modulates DMS activity via 5-HT1BR in a behavior-specific manner.

Conclusions:

  • Serotonin, acting through 5-HT1BR, plays a critical role in modulating DMS neural activity during reward processing and impulsivity.
  • The study highlights the importance of in vivo approaches to understand serotonin's functional role in the DMS.
  • Serotonin's influence on DMS function is context-dependent, providing a mechanism for its varied behavioral effects.